MedTrace Logo

Platelet Activity in T2DM Using Flowcytometry

NCT04027907 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2019-07-22

No results posted yet for this study

Summary

-Describe platelet activity in type 2 diabetes as a participant in vascular inflammation. -Compare platelet activity in patients with type 2 diabetes mellitus versus healthy controls. -Study and describe platelet activity in patients with type 2 diabetes mellitus in association with ischemic cardiovascular disease in relation to duration of diabetes mellitus .

Conditions

  • Platelet Activity in T2DM Using Flowcytometry

Interventions

OTHER

Flowcytometry

detect platelet activity in T2DM by surface expression of platelet receptors determined by flowcytometry using different monoclonal antibodies (CD62 and CD63).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • hanaa ahmed, master · Assiut University

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-10-01
Completion
2021-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027907 on ClinicalTrials.gov